Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gordon

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Clinical Epigenetics|January 3, 2024
MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancerHanghang Zhang, Chen Huang, John Gordon, et al.
Nature Communications|April 3, 2025
Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Critical Care Explorations|March 20, 2026
Ceragenin-Coated Endotracheal Tubes for the Reduction of Ventilator-Associated Pneumonia: A Prospective, Longitudinal, Crossover, Interrupted Time, Implementation Study (CEASE VAP Study)John Muscedere, Patrick A Norman, Christine D'Arsigney, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Novel inhibitors of acute, axonal DLK palmitoylation are neuroprotective and avoid the deleterious side effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Trials|September 30, 2016
Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trialJohn Muscedere, David Maslove, John Gordon Boyd, et al.
The British Journal of Nutrition|December 10, 2009
The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intakeJohn Gordon Bell, Deborah Miller, Donald J MacDonald, et al.
Journal of Medicinal Chemistry|September 25, 2024
First Demonstration of <i>In Vivo</i> PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory DisordersShams Ul Mahmood, Jeremy Eberhard, Charles S Hoffman, et al.
Oncogene|August 11, 2005
Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growthAmanda J Baxendale, Chris W Dawson, Suzanne E Stewart, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|December 12, 2012
Flexible services for the support of researchMatteo Turilli, David Wallom, Chris Williams, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 31, 2015
Nutritional Online Information for Cancer Patients: a Randomized Trial of an Internet Communication Plus Social Media InterventionPatrizia Gnagnarella, Alessandro Maria Misotti, Luigi Santoro, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Clinical Epigenetics|January 3, 2024
MC180295 is a highly potent and selective CDK9 inhibitor with preclinical in vitro and in vivo efficacy in cancerHanghang Zhang, Chen Huang, John Gordon, et al.
Nature Communications|April 3, 2025
Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Critical Care Explorations|March 20, 2026
Ceragenin-Coated Endotracheal Tubes for the Reduction of Ventilator-Associated Pneumonia: A Prospective, Longitudinal, Crossover, Interrupted Time, Implementation Study (CEASE VAP Study)John Muscedere, Patrick A Norman, Christine D'Arsigney, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Novel inhibitors of acute, axonal DLK palmitoylation are neuroprotective and avoid the deleterious side effects of cell-wide DLK inhibitionXiaotian Zhang, Heykyeong Jeong, Jingwen Niu, et al.
Trials|September 30, 2016
Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trialJohn Muscedere, David Maslove, John Gordon Boyd, et al.
The British Journal of Nutrition|December 10, 2009
The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intakeJohn Gordon Bell, Deborah Miller, Donald J MacDonald, et al.
Journal of Medicinal Chemistry|September 25, 2024
First Demonstration of <i>In Vivo</i> PDE11A4 Target Engagement for Potential Treatment of Age-Related Memory DisordersShams Ul Mahmood, Jeremy Eberhard, Charles S Hoffman, et al.
Oncogene|August 11, 2005
Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growthAmanda J Baxendale, Chris W Dawson, Suzanne E Stewart, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|December 12, 2012
Flexible services for the support of researchMatteo Turilli, David Wallom, Chris Williams, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 31, 2015
Nutritional Online Information for Cancer Patients: a Randomized Trial of an Internet Communication Plus Social Media InterventionPatrizia Gnagnarella, Alessandro Maria Misotti, Luigi Santoro, et al.
Pageof 15